, Volume 33, Issue 6, pp 789–802 | Cite as

A Preliminary Videofluoroscopic Investigation of Swallowing Physiology and Function in Individuals with Oculopharyngeal Muscular Dystrophy (OPMD)

  • Ashley A. WaitoEmail author
  • Catriona M. Steele
  • Melanie Peladeau-Pigeon
  • Angela Genge
  • Zohar Argov
Original Article


Dysphagia is one of the primary symptoms experienced by individuals with Oculopharyngeal Muscular Dystrophy (OPMD). However, we lack understanding of the discrete changes in swallowing physiology that are seen in OPMD, and the resulting relationship to impairments of swallowing safety and efficiency. This study sought to describe the pathophysiology of dysphagia in a small sample of patients with OPMD using a videofluoroscopy examination (VFSS) involving 3 × 5 mL boluses of thin liquid barium (22% w/v). The aim of this study is to extend what is known about the pathophysiology of dysphagia in OPMD, by quantifying changes in swallow timing, kinematics, safety, and efficiency, measured from VFSS. This study is a secondary analysis of baseline VFSS collected from 11 adults (4 male), aged 48–62 (mean 57) enrolled in an industry-sponsored phase 2 therapeutic drug trial. Blinded raters scored the VFSS recordings for safety [Penetration-Aspiration Scale (PAS)], efficiency [Normalized Residue Ratio Scale (NRRS)], timing [Pharyngeal Transit Time (PTT), Swallow Reaction Time (SRT), Laryngeal Vestibule Closure Reaction Time (LVCrt), Upper Esophageal Sphincter Opening Duration (UESD)], and kinematics (hyoid movement, pharyngeal constriction, UES opening width). Impairment thresholds from existing literature were defined to characterize swallowing physiology and function. Further, Fisher’s Exact tests and Pearson’s correlations were used to conduct a preliminary exploration of associations between swallowing physiology (e.g., kinematics, timing) and function (i.e., safety, efficiency). Compared to published norms, we identified significant differences in the degree of maximum pharyngeal constriction, hyoid movement distance and speed, as well as degree and timeliness of airway closure. Unsafe swallowing (PAS ≥ 3) was seen in only 3/11 patients. By contrast, clinically significant residue (i.e., NRRS scores ≥ 0.09 vallecular; ≥ 0.2 pyriform) was seen in 7/11 patients. Fisher’s Exact tests revealed associations between prolonged SRT, PTT, and unsafe swallowing. Weak associations were also identified between post-swallow residue and poor pharyngeal constriction during the swallow. Detailed analysis of swallowing physiology in this series of adults with OPMD aligns with impaired muscular function (e.g., reduced pharyngeal constriction, incomplete laryngeal vestibule closure) associated with the disease, and primary functional challenges with swallow efficiency. Further work is needed to explore a greater range of food and liquid textures, and to identify additional physiological mechanisms underlying swallowing impairment in OPMD.


Deglutition disorders Oculopharyngeal muscular dystrophy Videofluoroscopy Aspiration Post-swallow residue Swallow kinematics Swallow timing 



The authors wish to thank Irit Gliko-Kabir, PhD, formerly Senior Director Clinical Development with BioBlast Pharma for her role in study design and data collection, as well as Dr. Warren Wasiewski for his comments on an earlier version of this manuscript. We also gratefully acknowledge Vivian Chak, Robbyn Draimin, Ashwini Namasivayam, Sonya Torreiter, Teresa Valenzano, and Talia Wolkin for their assistance with data analysis.


Funding for this study was provided by BioBlast Pharma Ltd., Tel Aviv, Israel.

Compliance with Ethical Standards

Ethical Approval

This is a secondary analysis of data from a clinical drug trial. The original study received Human Subjects approval from the institutional research ethics board, and informed consent was obtained from all individual participants.

Conflicts of interest

The authors have no conflicts of interest to disclose.


  1. 1.
    Brais B. Oculopharyngeal muscular dystrophy. Handb Clin Neurol. 2011;101:181–92. Scholar
  2. 2.
    Abu-Baker A, Rouleau GA. Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies. Biochim Biophys Acta. 2007;1772(2):173–85. Scholar
  3. 3.
    Tomé FMS, Chateau D, Helbling-Leclerc A, Fardeau M. Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy. Neuromuscul Disord. 1997;7:S63–9. Scholar
  4. 4.
    Young EC, Durant-Jones L. Gradual onset of dysphagia: a study of patients with oculopharyngeal muscular dystrophy. Dysphagia. 1997;12(4):196–201. Scholar
  5. 5.
    Bouchard JP, Brais B, Brunet D, Gould PV, Rouleau GA. Recent studies on oculopharyngeal muscular dystrophy in Québec. Neuromuscul Disord. 1997;7(Suppl 1):S22–9.CrossRefGoogle Scholar
  6. 6.
    Van Der Sluijs BM, Hoefsloot LH, Padberg GW, Van Der Maarel SM, Van Engelen BG. Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint. J Neurol. 2003;250(11):1307–12. Scholar
  7. 7.
    Miller RM, Britton D. Dysphagia in neuromuscular diseases. San Diego: Plural Publishing; 2011.Google Scholar
  8. 8.
    Blumen SC, Bouchard JP, Brais B, Carasso RL, Paleacu D, Drory VE, Chantal S, Blumen N, Braverman I. Cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes. Neurology. 2009;73(8):596–601. Scholar
  9. 9.
    Mizoi Y, Yamamoto T, Minami N, Ohkuma A, Nonaka I, Nishino I, Tamura N, Amano T, Araki N. Oculopharyngeal muscular dystrophy associated with dementia. Intern Med. 2011;50(20):2409–12.CrossRefGoogle Scholar
  10. 10.
    van der Sluijs BM, te Riele MGE, Hammink JKN, Ramdhani-Joosten AAJ, Snijders AH, Raz V, van Engelen BGM, Voermans NC. Oculopharyngeal muscular dystrophy with frontotemporal dementia. Eur Geriatr Med. 2017;8(1):81–3.CrossRefGoogle Scholar
  11. 11.
    Duranceau A. Cricopharyngeal myotomy in the management of neurogenic and muscular dysphagia. Neuromuscul Disord. 1997;7(Suppl 1):S85–9.CrossRefGoogle Scholar
  12. 12.
    Duranceau CA, Letendre J, Clermont RJ, Lévesque HP, Barbeau A. Oropharyngeal dysphagia in patients with oculopharyngeal muscular dystrophy. Can J Surg. 1978;21(4):326–9.PubMedGoogle Scholar
  13. 13.
    Tabor LC, Plowman EK, Romero-Clark C, Youssof S. Oropharyngeal dysphagia profiles in individuals with oculopharyngeal muscular dystrophy. Neurogastroenterol Motility. 2017. Scholar
  14. 14.
    Palmer PM, Romero-Clark C, Coe T, Morrison L, Garrison K, Wiest P. Swallow deficits in a Northern New Mexico cohort of patients with OPMD. Dysphagia. 2006;21(4):321.Google Scholar
  15. 15.
    Palmer PM, Neel AT, Sprouls G, Morrison L. Swallow characteristics in patients with oculopharyngeal muscular dystrophy. J Speech Lang Hear Res. 2010;53(6):1567–78. Scholar
  16. 16.
    Castell JA, Castell DO, Duranceau CA, Topart P. Manometric characteristics of the pharynx, upper esophageal sphincter, esophagus, and lower esophageal sphincter in patients with oculopharyngeal muscular dystrophy. Dysphagia. 1995;10(1):22–6.CrossRefGoogle Scholar
  17. 17.
    Werling S, Schrank B, Eckardt AJ, Hauburger A, Deschauer M, Müller M. Oculopharyngeal muscular dystrophy as a rare cause of dysphagia. Ann Gastroenterol. 2015;28(2):291–3.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Duranceau A, Forand MD, Fauteux JP. Surgery in oculopharyngeal muscular dystrophy. Am J Surg. 1980;139(1):33–9.CrossRefGoogle Scholar
  19. 19.
    Bouchard J, Marcoux S, Gosselin F, Pineault D, Rouleau G. A simple test for the detection of the dysphagia in members of families with oculopharyngeal muscular dystrophy (OPMD). Can J Neurol Sci. 1992;19:296–7.Google Scholar
  20. 20.
    Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia. 1996;11(2):93–8.CrossRefGoogle Scholar
  21. 21.
    Pearson WG Jr, Molfenter SM, Smith ZM, Steele CM. Image-based measurement of post-swallow residue: the normalized residue ratio scale. Dysphagia. 2013;28(2):167–77. Scholar
  22. 22.
    Molfenter SM, Steele CM. Use of an anatomical scalar to control for sex-based size differences in measures of hyoid excursion during swallowing. J Speech Lang Hear Res. 2014;57(3):768–78. Scholar
  23. 23.
    Molfenter SM, Steele CM. Kinematic and temporal factors associated with penetration-aspiration in swallowing liquids. Dysphagia. 2014;29(2):269–76. Scholar
  24. 24.
    Nagy A, Molfenter SM, Peladeau-Pigeon M, Stokely S, Steele CM. The effect of bolus consistency on hyoid velocity in healthy swallowing. Dysphagia. 2015;30(4):445–51. Scholar
  25. 25.
    Nagy A, Molfenter SM, Peladeau-Pigeon M, Stokely S, Steele CM. The effect of bolus volume on hyoid kinematics in healthy swallowing. Biomed Res Int. 2014;2014:738971. Scholar
  26. 26.
    Leonard R, Kendall K, McKenzie S. UES opening and cricopharyngeal bar in nondysphagic elderly and nonelderly adults. Dysphagia. 2004;19(3):182–91.CrossRefGoogle Scholar
  27. 27.
    Stokely SL, Peladeau-Pigeon M, Leigh C, Molfenter SM, Steele CM. The relationship between pharyngeal constriction and post-swallow residue. Dysphagia. 2015;30(3):349–56. Scholar
  28. 28.
    Robbins J, Hamilton JW, Lof GL, Kempster GB. Oropharyngeal swallowing in normal adults of different ages. Gastroenterology. 1992;103(3):823.CrossRefGoogle Scholar
  29. 29.
    Humbert IA, Lokhande A, Christopherson H, German R, Stone A. Adaptation of swallowing hyo-laryngeal kinematics is distinct in oral vs. pharyngeal sensory processing. J Appl Physiol. 2012;112(10):1698–705.CrossRefGoogle Scholar
  30. 30.
    Young JL, Macrae P, Anderson C, Taylor-Kamara I, Humbert IA. The sequence of swallowing events during the chin-down posture. Am J Speech Lang Pathol. 2015;24(4):659–70.CrossRefGoogle Scholar
  31. 31.
    Logemann JA. The evaluation and treatment of swallowing disorders. Curr Opin Otolaryngol Head Neck Surg. 1998;6(6):395–400.CrossRefGoogle Scholar
  32. 32.
    Guedes R, Azola A, Macrae P, Sunday K, Mejia V, Vose A, Humbert IA. Examination of swallowing maneuver training and transfer of practiced behaviors to laryngeal vestibule kinematics in functional swallowing of healthy adults. Physiol Behav. 2017;174:155–61. Scholar
  33. 33.
    Macrae P, Anderson C, Humbert I. Mechanisms of airway protection during chin-down swallowing. J Speech Lang Hear Res (JSLHR). 2014;57(4):1251.CrossRefGoogle Scholar
  34. 34.
    Molfenter SM, Steele CM. The relationship between residue and aspiration on the subsequent swallow: an application of the normalized residue ratio scale. Dysphagia. 2013;28(4):494–500. Scholar
  35. 35.
    Molfenter SM, Cliffe Polacco R, Steele CM. The validity of multiple swallows per bolus as a sign of swallowing impairment. Paper presented at the European Society for Swallowing Disorders, Leiden, The Netherlands, September 2011.Google Scholar
  36. 36.
    Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–63. Scholar
  37. 37.
    Daniels SK, Schroeder MF, DeGeorge PC, Corey DM, Rosenbek JC. Effects of verbal cue on bolus flow during swallowing. Am J Speech Lang Pathol. 2007;16(2):140–7.CrossRefGoogle Scholar
  38. 38.
    Steele CM, Chak V, Dhindsa A, Dramin RD, Nagy A, Peladeau-Pigeon M, Tapson M, Torreiter S, Wolkin T, Waito AA. Timing plays a major role in the pathophysiology of aspiration. Dysphagia. 2015.Google Scholar
  39. 39.
    Nativ-Zeltzer N, Logemann JA, Kahrilas PJ. Comparison of timing abnormalities leading to penetration versus aspiration during the oropharyngeal swallow. Laryngoscope. 2014;124(4):935–41. Scholar
  40. 40.
    Chang MH, Chang SP, Cheung SC, Kong KW. Computerized tomography of oropharynx is useful in the diagnosis of oculopharyngeal muscular dystrophy. Muscle Nerve. 1993;16(3):325.PubMedGoogle Scholar
  41. 41.
    Steele CM, Cichero JA. Physiological factors related to aspiration risk: a systematic review. Dysphagia. 2014;29(3):295–304. Scholar
  42. 42.
    Kahrilas PJ, Lin S, Rademaker AW, Logemann JA. Impaired deglutitive airway protection: a videofluoroscopic analysis of severity and mechanism. Gastroenterology. 1997;113(5):1457–64.CrossRefGoogle Scholar
  43. 43.
    Yunusova Y, Green JR, Lindstrom MJ, Ball LJ, Pattee GL, Zinman L. Kinematics of disease progression in bulbar ALS. J Commun Disord. 2010;43(1):6–20. Scholar
  44. 44.
    Youssof S, Schrader RM, Romero-Clark C, Roy G, Spafford M. Safety of botulinum toxin for dysphagia in oculopharyngeal muscular dystrophy. Muscle Nerve. 2014;49(4):601–3. Scholar
  45. 45.
    Duranceau AC, Beauchamp G, Jamieson GG, Barbeau A. Oropharyngeal dysphagia and oculopharyngeal muscular dystrophy. Surg Clin N Am. 1983;63(4):825–32.CrossRefGoogle Scholar
  46. 46.
    de Swart BJ, van der Sluijs BM, Vos AM, Kalf JG, Knuijt S, Cruysberg JR, van Engelen BG. Ptosis aggravates dysphagia in oculopharyngeal muscular dystrophy. J Neurol Neurosurg Psychiatry. 2006;77(2):266–8. Scholar
  47. 47.
    Neel AT, Palmer PM, Sprouls G, Morrison L. Tongue strength and speech intelligibility in oculopharyngeal muscular dystrophy. J Med Speech Lang Pathol. 2006;14(4):273–7.Google Scholar
  48. 48.
    Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Ashley A. Waito
    • 1
    • 2
    Email author
  • Catriona M. Steele
    • 1
    • 2
  • Melanie Peladeau-Pigeon
    • 1
  • Angela Genge
    • 3
  • Zohar Argov
    • 4
  1. 1.Swallowing Rehabilitation Research LaboratoryToronto Rehabilitation Institute - University Health NetworkTorontoCanada
  2. 2.Rehabilitation Sciences InstituteUniversity of TorontoTorontoCanada
  3. 3.Montreal Neurological Institute and HospitalMcGill UniversityMontrealCanada
  4. 4.BioBlast Pharma Ltd.Tel AvivIsrael

Personalised recommendations